ClinicalTrials.Veeva

Menu

Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment (QALYBHRe)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Withdrawn

Conditions

Bacterial Infections

Treatments

Other: Quality of life questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT04226001
69HCL19_0022
2019-A00074-53 (Other Identifier)

Details and patient eligibility

About

The quality of life of carriers detected infected or colonized by emerging highly resistant bacteria (BHRe) following the implementation of specific hygiene measures during the discovery of the microorganism has been little studied. To date, there have been no studies to determine the quality of life (QoL) in France of patients with hospitalized HBHRD.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age> 18 years old
  • Have a positive BHRe screening during the hospital stay and / or have a positive BHRe clinical sample during the hospital stay
  • Conscious patients
  • All types of stays in the hospital sector
  • All pathologies

Exclusion criteria

  • Known patients with BHRe before hospitalization
  • PCH immediately upon admission (history of hospitalization abroad, patients contacted during a previous hospitalization)
  • Cognitive problem
  • Patients not proficient in French (requiring an interpreter)
  • Patients under guardianship

Trial design

0 participants in 1 patient group

Patients
Description:
Patients screened for carriers infected or colonized by emerging highly resistant bacteria.
Treatment:
Other: Quality of life questionnaire

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems